Strides Pharma arm receives USFDA nod for potassium chloride oral solution

Strides Pharma Global, Singapore, has received approval for Potassium Chloride for Oral Solution USP, 20 mEq from the United States Food and Drug Administration (USFDA), Strides Pharma Science said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OOMcLU
via IFTTT